Dodge & Cox Stock Fund Zimmer Biomet Holdings Inc transactions over time
ZBH
Zimmer Biomet Holdings Inc historical holders
total: 14
Transactions details
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 10
- Held since:
- 2022 Q1
- Held for:
- 18 quarters
- Latest activity:
- 2025 Q3
Dodge & Cox Stock Fund has been an institutional investor in Zimmer Biomet Holdings Inc (ZBH) since 2022 Q1. According to 2026 Q2 report, Dodge & Cox Stock Fund holds 15,549,900 shares with a market value of roughly $1.34B representing 1.13% of their equity portfolio. The fund/company first acquired ZBH in 2022 Q1, initially purchasing about 1.45M shares. Since the initial investment, Dodge & Cox Stock Fund has made 10 more transactions in this position.
Does Dodge & Cox Stock Fund still hold ZBH?
Yes, Dodge & Cox Stock Fund continues to hold Zimmer Biomet Holdings Inc (ZBH). According to their 2026 Q2 report, they maintain a position of 15,549,900 shares valued at approximately $1.34B, representing 1.13% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in ZBH?
Dodge & Cox Stock Fund first invested in Zimmer Biomet Holdings Inc (ZBH) in 2022 Q1 at the reported quarter-end price of $127.90 per share, acquiring 1,451,589 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for ZBH?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for Zimmer Biomet Holdings Inc (ZBH) is approximately $115.21 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $115.21
ZBH transactions history by Dodge & Cox Stock Fund
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
1.27%
|
15,549,900
|
$98.50
|
$1,531,665,150
|
+6.34% (+927,500)
|
+0.08%
|
|
2025 Q2
|
1.14%
|
14,622,400
|
$91.21
|
$1,333,709,104
|
+13.95% (+1,789,700)
|
+0.14%
|
|
2025 Q1
|
1.28%
|
12,832,700
|
$113.18
|
$1,452,404,986
|
+2.47% (+309,100)
|
+0.03%
|
|
2024 Q4
|
1.19%
|
12,523,600
|
$105.63
|
$1,322,867,868
|
+15.15% (+1,647,500)
|
+0.16%
|
|
2024 Q1
|
1.31%
|
10,876,100
|
$131.98
|
$1,435,427,678
|
+44.14% (+3,330,500)
|
+0.4%
|
|
2023 Q4
|
0.91%
|
7,545,600
|
$121.70
|
$918,299,520
|
+96.80% (+3,711,400)
|
+0.45%
|
|
2023 Q3
|
0.47%
|
3,834,200
|
$112.22
|
$430,273,924
|
+0.55% (+21,000)
|
+0%
|
|
2023 Q2
|
0.60%
|
3,813,200
|
$145.60
|
$555,201,920
|
+0.36% (+13,800)
|
+0%
|
|
2022 Q3
|
0.50%
|
3,799,400
|
$104.55
|
$397,227,270
|
+0.20% (+7,500)
|
+0%
|
|
2022 Q2
|
0.47%
|
3,791,900
|
$105.06
|
$398,377,014
|
+161.22% (+2,340,311)
|
+0.29%
|
|
2022 Q1
|
0.19%
|
$127.90
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.